Treatment of the LOUCY acute lymphoblastic leukemia cell line with HG-9-91-01 restored normal T-cell development (247), therefore suggesting that the SIKs impact lymphoid lineage decision-making via regulating MEF2C activity. Here, MEF2C is linked to acute lymphoblastic leukemia.